Abstract

TPS2611Background: Over expression and aberrant function of ErbB receptor tyrosine kinases (EGFR, HER2, HER3 and HER4) contributes to tumorigenesis. Multiple drugs targeting EGFR or HER2 are alread...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Consensus conference on unrelated donor bone marrow transplatation: its use in leukemias and allied disorders
Ma Farqhuar
Leukemia | VOL. 11
Ma FarqhuarMa Farqhuar
01 Mar 1997
Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.
Jing-Jing Lu ... Yan-Hui Ma
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | VOL. 39
Jing-Jing Lu, et. al.Jing-Jing Lu ... Yan-Hui Ma
01 May 2017
Expression and Function of Murine Receptor Tyrosine Kinases, TIE and TEK, in Hematopoietic Stem Cells
Toshio Suda ... Goro Takada
Blood | VOL. 89
Toshio Suda, et. al.Toshio Suda ... Goro Takada
15 Jun 1997
Expression of Receptor Tyrosine Kinases on Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes in Patients with Renal Cell Carcinoma and Healthy Donors
Grigory Raskin ... Dmitry Khochenkov
Oncology | VOL. 98
Grigory Raskin, et. al.Grigory Raskin ... Dmitry Khochenkov
13 Feb 2020
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Cristina Astrid Tentori ... Fabio Ciceri
Journal of Clinical Oncology | VOL. -
Cristina Astrid Tentori, et. al.Cristina Astrid Tentori ... Fabio Ciceri
09 May 2024
Addressing Disability in Cancer Survivors
Rachelle Brick ... Emily S Tonorezos
Journal of Clinical Oncology | VOL. -
Rachelle Brick, et. al.Rachelle Brick ... Emily S Tonorezos
09 May 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Susanna Hegewisch-Becker ... Niall C Tebbutt
Journal of Clinical Oncology | VOL. -
Susanna Hegewisch-Becker, et. al.Susanna Hegewisch-Becker ... Niall C Tebbutt
09 May 2024
A pivotal phase 2 single-arm study of glecirasib (JAB-21822) in patients with NSCLC harboring KRAS G12C mutation.
Yuankai Shi ... Zhengbo Song
Journal of Clinical Oncology | VOL. 42
Yuankai Shi, et. al.Yuankai Shi ... Zhengbo Song
30 Apr 2024
View more papers